Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartwatch-Like device could help test DMD drugs in toddlers

NCT ID NCT07423026

Knowledge-focused Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a watch-like device worn on the ankle can measure how well toddlers with Duchenne muscular dystrophy (DMD) move during their daily activities. Researchers will ask 30 boys with DMD and 30 without (ages 1-3) to wear the device for three 28-day periods over six months. The goal is to see if the device is comfortable, reliable, and can detect changes in walking ability, which could help test new medicines in younger children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Syde wearable device (ankle-worn activity monitor)
What this could lead to
If successful, this could provide a way to test new DMD medicines in very young children, potentially speeding up development of treatments.
What could go wrong
This is a small, early-stage feasibility study (60 boys) focused on measurement, not treatment. The device may not work well in toddlers or may not detect meaningful changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants with DMD and healthy controls within the UK, identified via advertisements and through clinic lists.

Ages

1 year to 3 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participant with DMD: * Male * Aged 1-3 years old * Ambulant (walking 10m independently) * Genetically confirmed diagnosis of DMD * Parent(s)/legal guardian(s) able and willing to provide written informed consent for the child to participate in the study * Parent(s)/legal guardian(s) able and willing to participate in the study Parent/legal guardian of participant with DMD: * Aged 18 years or more * Legal carer of the patient diagnosed with DMD * Willingness to follow study procedures and assist with remote assessments, as assessed by the research team * Willingness to sign the consent form * Ability to understand all the information with regards to the study, as assessed by the research team Healthy Control participant: * Male * Aged 1-3 years old * Ambulant (walking 10m independently) * Parent(s)/legal guardian Exclusion Criteria: Participant with DMD: * Limb surgery/trauma (within 6 months) * Significant comorbid chronic or acute conditions affecting motor function (within 3 weeks) * Prematurity (born \<37 weeks' gestation) * Oral corticosteroids to treat DMD (before enrolment) * Enrolment in therapeutic clinical trials * Any comorbidity which could limit their ability to complete the study assessments (according to the investigator's clinical judgement) Healthy Control participant: * Limb surgery/trauma (within 6 months) * Significant comorbid chronic condition affecting motor function * Significant acute condition affecting motor function (within 3weeks of enrolment) * Prematurity (born \<37 weeks' gestation) * Neurodevelopmental concerns or delay in acquisition of WHO developmental milestones. * Any comorbidity which could limit their ability to complete the study assessments (according to the investigator's clinical judgement).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Duchenne muscular dystrophy (DMD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Duchenne muscular dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Duchenne muscular dystrophy (DMD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Oxford University

    RECRUITING

    Oxford, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.